Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 187   

Articles published

AZN 4,749.50 -80.50 (-1.67%)
price chart
Everything You Need To Know From AstraZeneca plc's Q1 Results
Pharma giant AstraZeneca (LSE: AZN) reported its results for the first quarter of 2015 today, and while headline revenue fell, the group reported strong growth in key areas.
AstraZeneca plc Has a Rocky First-Quarter: Here's What You Need to Know  Motley Fool
Are Investors Betting On Pfizer Inc. Coming Back For AstraZeneca plc?
AstraZeneca is currently valued at 4,851p a share, which is in line with the level it recorded in early May 2014, when investors were eager to bet on a successful outcome for Pfizer's proposed offer.
AstraZeneca plc Given Hold Rating at Berenberg Bank (AZN)
AstraZeneca plc (NYSE:AZN) traded down 1.83% on Friday, hitting $71.79. 1,876,593 shares of the company's stock traded hands.
AstraZeneca plc's Buy Rating Reiterated at Credit Suisse Group AG (AZN)  Dakota Financial News
Jefferies Group Reaffirms "Buy" Rating for AstraZeneca plc (AZN)  Mideast Time
5 Top Dividend Stocks: AstraZeneca plc, Imperial Tobacco Group PLC, Pennon ...
Even though AstraZeneca (LSE: AZN) is set to maintain dividends per share over the next two years (rather than grow them), it continues to be a highly appealing income stock.
Why AstraZeneca plc Is Neil Woodford's Top Holding
The famed income investor Neil Woodford has put almost 8% of his flagship fund's money into one company, AstraZeneca (LSE: AZN).
AstraZeneca plc vs Smith & Nephew plc vs Indivior PLC: Which Healthcare Stock ...
For example, during the last five years AstraZeneca has seen its earnings decline by an incredible 33%, as it has been unable to replace a number of key, blockbuster drugs that have lost their patent protection.
AstraZeneca plc Upgraded by Redburn Partners to "Buy" (AZN)  The Legacy
Redburn Partners Upgrades AstraZeneca plc to Buy (AZN)  sleekmoney
AstraZeneca plc (ADR) (AZN) Q1 Profits Decline Amid Patent Expiry Of Top Drugs
British pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN), announced its first quarter financial results for fiscal'15 before the market opened in London on Friday.
AstraZeneca PLC (AZN.L) Releases Earnings Results, Beats Estimates By $0.03 ...  Mideast Time
Options Players Hone in on AstraZeneca PLC  AVAFIN
Why AstraZeneca plc Beats GlaxoSmithKline plc
Businesses that don't invest for the future struggle to survive over the long term. And the companies that spend the most on research and development often have the best growth prospects.
Earnings Preview: Juniper Networks, Inc., American Airlines Group Inc., and ...
Among the stocks gearing up to report earnings are tech concern Juniper Networks, Inc. (NYSE:JNPR), airline issue American Airlines Group Inc. (NASDAQ:AAL), and biotech firm AstraZeneca plc (ADR) (NYSE:AZN). Below, we'll take the pre-earnings ...
Morningstar Issues AA- Credit Rating to AstraZeneca plc (AZN)
AstraZeneca plc logo AstraZeneca plc (NYSE:AZN) has earned an �AA-� credit rating from analysts at Morningstar. The investment research firm's �AA-� rating indicates that the company is a very-low default risk.
AstraZeneca plc Given Buy Rating at Societe Generale (AZN)  Mideast Time